Skip to content

Journal of Medical Regulation Examines Global Regulatory Topics in Current Issue

Washington, D.C. (June 5, 2018) – The Journal of Medical Regulation has published three articles that address global topics in medical regulation – ranging from the need for better sharing of data among regulators internationally to warnings about the distribution of counterfeit or contaminated drugs. 

Appearing in Volume 104, #1, the articles include: 

A Data Model for Medical Schools and their Programs: Structuring Data to Inform Medical Regulation Worldwide
The authors address the growing incidence of telemedicine, medical tourism and international workforce mobility with ideas that promote common understandings of educational requirements from country to country. 

The Dangers of Buying Prescription Drugs from Rogue Wholesale Distributors
A commentary from the U.S. Food and Drug Administration warns of the dangers of rogue wholesale drug distributors — who, in today’s increasingly fluid global distribution system, are able to introduce unapproved, counterfeit, contaminated or ineffective drugs into the hands of physicians and patients. 

A Glossary in Support of Physicians’ Continuing Professional Development Across the World
Authors from the International Academy for CPD Accreditation note the critical need for global health systems to unite around a common terminology as they establish standards for continuing professional development. 

To read a full copy of the Journal, please click here

The Journal of Medical Regulation is a quarterly publication of the Federation of State Medical Boards. 

About the Federation of State Medical Boards
The Federation of State Medical Boards (FSMB) is a national non-profit organization representing all medical boards within the United States and its territories that license and discipline allopathic and osteopathic physicians and, in some jurisdictions, other health care professionals. The FSMB serves as the voice for state medical boards, supporting them through education, assessment, research and advocacy while providing services and initiatives that promote patient safety, quality health care and regulatory best practices. To learn more about FSMB, visit You can also follow FSMB on Twitter (@theFSMB).